317 related articles for article (PubMed ID: 18990505)
1. Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients.
Franckena M; Lutgens LC; Koper PC; Kleynen CE; van der Steen-Banasik EM; Jobsen JJ; Leer JW; Creutzberg CL; Dielwart MF; van Norden Y; Canters RA; van Rhoon GC; van der Zee J
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):242-50. PubMed ID: 18990505
[TBL] [Abstract][Full Text] [Related]
2. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial.
Franckena M; Stalpers LJ; Koper PC; Wiggenraad RG; Hoogenraad WJ; van Dijk JD; Wárlám-Rodenhuis CC; Jobsen JJ; van Rhoon GC; van der Zee J
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1176-82. PubMed ID: 17881144
[TBL] [Abstract][Full Text] [Related]
3. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency.
Vasanthan A; Mitsumori M; Park JH; Zhi-Fan Z; Yu-Bin Z; Oliynychenko P; Tatsuzaki H; Tanaka Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):145-53. PubMed ID: 15629605
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia.
Franckena M; Fatehi D; de Bruijne M; Canters RA; van Norden Y; Mens JW; van Rhoon GC; van der Zee J
Eur J Cancer; 2009 Jul; 45(11):1969-78. PubMed ID: 19361982
[TBL] [Abstract][Full Text] [Related]
5. Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB "bulky".
Sreenivasa G; Hildebrandt B; Kümmel S; Jungnickel K; Cho CH; Tilly W; Böhmer D; Budach V; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1159-67. PubMed ID: 16979843
[TBL] [Abstract][Full Text] [Related]
6. A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma.
Jones EL; Samulski TV; Dewhirst MW; Alvarez-Secord A; Berchuck A; Clarke-Pearson D; Havrilesky LJ; Soper J; Prosnitz LR
Cancer; 2003 Jul; 98(2):277-82. PubMed ID: 12872345
[TBL] [Abstract][Full Text] [Related]
7. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma.
Westermann AM; Jones EL; Schem BC; van der Steen-Banasik EM; Koper P; Mella O; Uitterhoeve AL; de Wit R; van der Velden J; Burger C; van der Wilt CL; Dahl O; Prosnitz LR; van der Zee J
Cancer; 2005 Aug; 104(4):763-70. PubMed ID: 15968685
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival.
Narayan K; van Dyk S; Bernshaw D; Rajasooriyar C; Kondalsamy-Chennakesavan S
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1529-35. PubMed ID: 19473780
[TBL] [Abstract][Full Text] [Related]
10. Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study.
Maluta S; Dall'Oglio S; Romano M; Marciai N; Pioli F; Giri MG; Benecchi PL; Comunale L; Porcaro AB
Int J Hyperthermia; 2007 Aug; 23(5):451-6. PubMed ID: 17701536
[TBL] [Abstract][Full Text] [Related]
11. Temperature data analysis for 22 patients with advanced cervical carcinoma treated in Rotterdam using radiotherapy, hyperthermia and chemotherapy: a reference point is needed.
Fatehi D; van der Zee J; van der Wal E; Van Wieringen WN; Van Rhoon GC
Int J Hyperthermia; 2006 Jun; 22(4):353-63. PubMed ID: 16754355
[TBL] [Abstract][Full Text] [Related]
12. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
[TBL] [Abstract][Full Text] [Related]
13. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
Parker K; Gallop-Evans E; Hanna L; Adams M
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
[TBL] [Abstract][Full Text] [Related]
14. Use of combined radiation and hyperthermia for gynecological cancer.
Franckena M; van der Zee J
Curr Opin Obstet Gynecol; 2010 Feb; 22(1):9-14. PubMed ID: 20019611
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
Novetsky AP; Einstein MH; Goldberg GL; Hailpern SM; Landau E; Fields AL; Mutyala S; Kalnicki S; Garg M
Gynecol Oncol; 2007 Jun; 105(3):635-40. PubMed ID: 17331568
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712
[TBL] [Abstract][Full Text] [Related]
17. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
Torbé B
Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
[TBL] [Abstract][Full Text] [Related]
19. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
[TBL] [Abstract][Full Text] [Related]
20. Accelerated hyperfractionated radiotherapy for cervical cancer: multi-institutional prospective study of forum for nuclear cooperation in Asia among eight Asian countries.
Ohno T; Nakano T; Kato S; Koo CC; Chansilpa Y; Pattaranutaporn P; Calaguas MJ; de Los Reyes RH; Zhou B; Zhou J; Susworo R; Supriana N; Dung TA; Ismail F; Sato S; Suto H; Kutsutani-Nakamura Y; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1522-9. PubMed ID: 17919839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
